Cosgrove, SE, Qi, Y, Kaye, KS, Harbarth, S, Karchmer, AW, Carmeli, Y., The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges (2005) Infect Control Hosp Epidemiol, 26, pp. 166-174; Roberts, RR, Scott, RD, Hota, B, Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods (2010) Med Care, 48, pp. 1026-1035; Davis, KA, Stewart, JJ, Crouch, HK, Florez, CE, Hospenthal, DR., Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection (2004) Clin Infect Dis, 39, pp. 776-782; Climo, M W, Yokoe, DS, Warren, DK, Effect of daily chlorhexidine bathing on hospital-acquired infection (2013) N Engl J Med, 368, pp. 533-542; Huang, SS, Septimus, E, Kleinman, K, Targeted versus universal decolonization to prevent ICU infection (2013) N Engl J Med, 368, pp. 2255-2265. , CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program; Huang, SS, Septimus, E, Kleinman, K, Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial (2019) Lancet, 393, pp. 1205-1215. , ABATE Infection Trial Team; Bleasdale, SC, Trick, WE, Gonzalez, IM, Lyles, RD, Hayden, MK, Weinstein, RA., Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients (2007) Arch Intern Med, 167, pp. 2073-2079; Lin, M Y, Lolans, K, Blom, DW, The effectiveness of routine daily chlorhexidine gluconate bathing in reducing Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients (2014) Infect Control Hosp Epidemiol, 35, pp. 440-442. , Centers for Disease Control and Prevention Epicenter Program; Milstone, AM, Passaretti, CL, Perl, TM., Chlorhexidine: expanding the armamentarium for infection control and prevention (2008) Clin Infect Dis, 46, pp. 274-281; Septimus, EJ, Schweizer, ML., Decolonization in prevention of health care-associated infections (2016) Clin Microbiol Rev, 29, pp. 201-222; Vernon, MO, Hayden, MK, Trick, WE, Hayes, RA, Blom, DW, Weinstein, RA, Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci (2006) Arch Intern Med, 166, pp. 306-312. , Chicago Antimicrobial Resistance Project (CARP); Sheldon, AT, Antiseptic "resistance": real or perceived threat? (2005) Clin Infect Dis, 40, pp. 1650-1656; Krautheim, AB, Jermann, TH, Bircher, AJ., Chlorhexidine anaphylaxis: case report and review of the literature (2004) Contact Dermatitis, 50, pp. 113-116; McDonnell, G, Russell, AD., Antiseptics and disinfectants: activity, action, and resistance (1999) Clin Microbiol Rev, 12, pp. 147-179; Supple, L, Kumaraswami, M, Kundrapu, S, Chlorhexidine only works if applied correctly: use of a simple colorimetric assay to provide monitoring and feedback on effectiveness of chlorhexidine application (2015) Infect Control Hosp Epidemiol, 36, pp. 1095-1097; Marschall, J, Mermel, LA, Fakih, M, Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update (2014) Infect Control Hosp Epidemiol, 35, pp. 753-771; Weiner, LM, Webb, AK, Walters, MS, Dudeck, MA, Kallen, AJ., Policies for controlling multidrug-resistant organisms in US healthcare facilities reporting to the national healthcare safety network, 2014 (2016) Infect Control Hosp Epidemiol, 37, pp. 1105-1108; Horner, C, Mawer, D, Wilcox, M., Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? (2012) J Antimicrob Chemother, 67, pp. 2547-2559; Kampf, G., Acquired resistance to chlorhexidine-is it time to establish an "antiseptic stewardship" initiative? (2016) J Hosp Infect, 94, pp. 213-227; Russell, AD., Bacterial resistance to disinfectants: present knowledge and future problems (1999) J Hosp Infect, 43, pp. S57-S68. , Suppl; Kõljalg, S, Naaber, P, Mikelsaar, M., Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility (2002) J Hosp Infect, 51, pp. 106-113; Babiker, A, Mustapha, MM, Pacey, M P, Use of online tools for antimicrobial resistance prediction by whole-genome sequencing in methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) (2019) J Glob Antimicrob Resist, 19, pp. 136-143; Smith, K, Gemmell, CG, Hunter, IS., The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates (2008) J Antimicrob Chemother, 61, pp. 78-84; Schlett, CD, Millar, E V, Crawford, KB, Prevalence of chlorhexidine-resistant methicillin-resistant Staphylococcus aureus following prolonged exposure (2014) Antimicrob Agents Chemother, 58, pp. 4404-4410; Conceição, T, Coelho, C, de Lencastre, H, Aires-de-Sousa, M., High prevalence of biocide resistance determinants in Staphylococcus aureus isolates from three African Countries (2016) Antimicrob Agents Chemother, 60, pp. 678-681; Longtin, J, Seah, C, Siebert, K, Distribution of antiseptic resistance genes qacA, qacB, and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, Canada, from 2005 to 2009 (2011) Antimicrob Agents Chemother, 55, pp. 2999-3001; McGann, P, Kwak, YI, Summers, A, Cummings, JF, Waterman, PE, Lesho, EP., Detection of qacA/B in clinical isolates of methicillin-resistant Staphylococcus aureus from a regional healthcare network in the eastern United States (2011) Infect Control Hosp Epidemiol, 32, pp. 1116-1119; Wang, JT, Sheng, WH, Wang, JL, Longitudinal analysis of chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan (2008) J Antimicrob Chemother, 62, pp. 514-517; Hayden, MK, Lolans, K, Haffenreffer, K, Chlorhexidine and mupirocin susceptibility of methicillin-resistant Staphylococcus aureus isolates in the REDUCE-MRSA trial (2016) J Clin Microbiol, 54, pp. 2735-2742; Hardy, K, Sunnucks, K, Gil, H, Increased usage of antiseptics is associated with reduced susceptibility in clinical isolates of Staphylococcus aureus (2018) mBio, 9, pp. e00894-18; Paulsen, IT, Brown, MH, Littlejohn, TG, Mitchell, BA, Skurray, RA., Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity (1996) Proc Natl Acad Sci USA, 93, pp. 3630-3635; Sheng, WH, Wang, JT, Lauderdale, TL, Weng, CM, Chen, D, Chang, SC., Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility (2009) Diagn Microbiol Infect Dis, 63, pp. 309-313; Abuzaid, A, Hamouda, A, Amyes, SG., Klebsiella pneumoniae susceptibility to bio-cides and its association with cepA, qacΔE and qacE efflux pump genes and antibiotic resistance (2012) J Hosp Infect, 81, pp. 87-91; McDanel, JS, Murphy, CR, Diekema, DJ, Chlorhexidine and mupirocin susceptibilities of methicillin-resistant Staphylococcus aureus from colonized nursing home residents (2013) Antimicrob Agents Chemother, 57, pp. 552-558; Fritz, SA, Hogan, PG, Camins, BC, Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections (2013) Antimicrob Agents Chemother, 57, pp. 559-568; Mc Gann, P, Milillo, M, Kwak, YI, Quintero, R, Waterman, PE, Lesho, E., Rapid and simultaneous detection of the chlorhexidine and mupirocin resistance genes qacA/B and mupA in clinical isolates of methicillin-resistant Staphylococcus au-reus (2013) Diagn Microbiol Infect Dis, 77, pp. 270-272; Vali, L, Davies, SE, Lai, LL, Dave, J, Amyes, SG., Frequency of biocide resistance genes, antibiotic resistance and the effect of chlorhexidine exposure on clinical methicillin-resistant Staphylococcus aureus isolates (2008) J Antimicrob Chemother, 61, pp. 524-532; Batra, R, Cooper, BS, Whiteley, C, Patel, AK, Wyncoll, D, Edgeworth, JD., Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit (2010) Clin Infect Dis, 50, pp. 210-217; Miyazaki, NH, Abreu, AO, Marin, VA, Rezende, CA, Moraes, MT, Villas Bôas, MH., The presence of qacA/B gene in Brazilian methicillin-resistant Staphylococcus au-reus (2007) Mem Inst Oswaldo Cruz, 102, pp. 539-540; Mayer, S, Boos, M, Beyer, A, Fluit, AC, Schmitz, FJ., Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and-susceptible European isolates of Staphylococcus aureus (2001) J Antimicrob Chemother, 47, pp. 896-897; Lee, H, Lim, H, Bae, IK, Coexistence of mupirocin and antiseptic resistance in methicillin-resistant Staphylococcus aureus isolates from Korea (2013) Diagn Microbiol Infect Dis, 75, pp. 308-312; Ridenour, G, Lampen, R, Federspiel, J, Kritchevsky, S, Wong, E, Climo, M., Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients (2007) Infect Control Hosp Epidemiol, 28, pp. 1155-1161; Johnson, MD, Schlett, CD, Grandits, GA, Chlorhexidine does not select for resistance in Staphylococcus aureus isolates in a community setting (2012) Infect Control Hosp Epidemiol, 33, pp. 1061-1063; Musuuza, JS, Sethi, AK, Roberts, TJ, Safdar, N., Analysis of multidrug-resistant organism susceptibility to chlorhexidine under usual clinical care (2017) Infect Control Hosp Epidemiol, 38, pp. 729-731; McNeil, JC, Kok, EY, Vallejo, JG, Clinical and molecular features of decreased chlorhexidine susceptibility among nosocomial Staphylococcus aureus isolates at Texas Children's Hospital (2016) Antimicrob Agents Chemother, 60, pp. 1121-1128; Warren, DK, Prager, M, Munigala, S, Prevalence of qacA/B genes and mupirocin resistance among methicillin-resistant Staphylococcus aureus (MRSA) isolates in the setting of chlorhexidine bathing without mupirocin (2016) Infect Control Hosp Epidemiol, 37, pp. 590-597; McNeil, JC, Hulten, KG, Kaplan, SL, Mahoney, DH, Mason, EO., Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications (2013) Pediatr Infect Dis J, 32, pp. 124-128; Zhang, M, O'Donoghue, MM, Ito, T, Hiramatsu, K, Boost, MV., Prevalence of antiseptic-resistance genes in Staphylococcus aureus and coagulase-negative staphylococci colonising nurses and the general population in Hong Kong (2011) J Hosp Infect, 78, pp. 113-117; Suwantarat, N, Carroll, KC, Tekle, T, High prevalence of reduced chlorhexi-dine susceptibility in organisms causing central line-associated bloodstream infections (2014) Infect Control Hosp Epidemiol, 35, pp. 1183-1186; Apisarnthanarak, A, Yang Hsu, L, Lim, TP, Mundy, LM., Increase in chlorhexidine minimal inhibitory concentration of Acinetobacter baumannii clinical isolates after implementation of advanced source control (2014) Infect Control Hosp Epidemiol, 35, pp. 98-99; Bhardwaj, P, Hans, A, Ruikar, K, Guan, Z, Palmer, KL., Reduced chlorhexidine and daptomycin susceptibility in vancomycin-resistant Enterococcus faecium after serial chlorhexidine exposure (2018) Antimicrob Agents Chemother, 62, pp. e01235-17; Fuangthong, M, Julotok, M, Chintana, W, Exposure of Acinetobacter baylyi ADP1 to the biocide chlorhexidine leads to acquired resistance to the biocide itself and to oxidants (2011) J Antimicrob Chemother, 66, pp. 319-322; Russell, AD, Tattawasart, U, Maillard, J Y, Furr, JR., Possible link between bacterial resistance and use of antibiotics and biocides (1998) Antimicrob Agents Chemother, 42, p. 2151; Thomas, L, Maillard, J Y, Lambert, RJ, Russell, AD., Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a "residual" concentration (2000) J Hosp Infect, 46, pp. 297-303; Bock, LJ, Wand, ME, Sutton, JM., Varying activity of chlorhexidine-based disinfectants against Klebsiella pneumoniae clinical isolates and adapted strains (2016) J Hosp Infect, 93, pp. 42-48; Naparstek, L, Carmeli, Y, Chmelnitsky, I, Banin, E, Navon-Venezia, S., Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae (2012) J Hosp Infect, 81, pp. 15-19; Edmiston, CE, Krepel, CJ, Seabrook, GR, Lewis, BD, Brown, KR, Towne, JB., Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission? (2008) J Am Coll Surg, 207, pp. 233-239; Popovich, KJ, Lyles, R, Hayes, R, Relationship between chlorhexidine gluconate skin concentration and microbial density on the skin of critically ill patients bathed daily with chlorhexidine gluconate (2012) Infect Control Hosp Epidemiol, 33, pp. 889-896; Alserehi, H, Filippell, M, Emerick, M, Chlorhexidine gluconate bathing practices and skin concentrations in intensive care unit patients (2018) Am J Infect Control, 46, pp. 226-228. , CDC Prevention Epicenter Program; Rhee, Y, Palmer, LJ, Okamoto, K, Differential effects of chlorhexidine skin cleansing methods on residual chlorhexidine skin concentrations and bacterial recovery (2018) Infect Control Hosp Epidemiol, 39, pp. 405-411. , Centers for Disease Control and Prevention Epicenter Program; Nadimpalli, G, O'Hara, LM, Leekha, S, Association between chlorhexidine gluconate concentrations and resistant bacterial bioburden on skin (2019) Infect Control Hosp Epidemiol, 40, pp. 1430-1432. , CDC Prevention Epicenter Program; Otter, JA, Patel, A, Cliff, PR, Halligan, E P, Tosas, O, Edgeworth, JD., Selection for qacA carriage in CC22, but not CC30, methicillin-resistant Staphylococcus aureus bloodstream infection isolates during a successful institutional infection control programme (2013) J Antimicrob Chemother, 68, pp. 992-999; Alam, MM, Kobayashi, N, Uehara, N, Watanabe, N., Analysis on distribution and ge-nomic diversity of high-level antiseptic resistance genes qacA and qacB in human clinical isolates of Staphylococcus aureus (2003) Microb Drug Resist, 9, pp. 109-121; Sidhu, MS, Heir, E, Leegaard, T, Wiger, K, Holck, A., Frequency of disinfectant resistance genes and genetic linkage with beta-lactamase transposon Tn552 among clinical staphylococci (2002) Antimicrob Agents Chemother, 46, pp. 2797-2803; DeMarco, CE, Cushing, LA, Frempong-Manso, E, Seo, SM, Jaravaza, TA, Kaatz, GW., Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus (2007) Antimicrob Agents Chemother, 51, pp. 3235-3239; Fernández-Cuenca, F, Tomás, M, Caballero-Moyano, FJ, Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps (2015) J Antimicrob Chemother, 70, pp. 3222-3229. , Spanish Group of Nosocomial Infections (GEIH) from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI); Cook, HA, Cimiotti, J P, Della-Latta, P, Saiman, L, Larson, EL., Antimicrobial resistance patterns of colonizing flora on nurses' hands in the neonatal intensive care unit (2007) Am J Infect Control, 35, pp. 231-236; Wand, ME, Bock, LJ, Bonney, LC, Sutton, JM., Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine (2017) Antimicrob Agents Chemother, 61. , AAC.01162-16; Stein, C, Vincze, S, Kipp, F, Makarewicz, O, Al Dahouk, S, Pletz, MW., Carbapenem-resistant Klebsiella pneumoniae with low chlorhexidine susceptibility (2019) Lancet Infect Dis, 19, pp. 932-933; Johnson, RC, Schlett, CD, Crawford, K, Lanier, JB, Merrell, DS, Ellis, M W., Recurrent methicillin-resistant Staphylococcus aureus cutaneous abscesses and selection of reduced chlorhexidine susceptibility during chlorhexidine use (2015) J Clin Microbiol, 53, pp. 3677-3682; Lee, AS, Macedo-Vinas, M, François, P, Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study (2011) Clin Infect Dis, 52, pp. 1422-1430; Sundermann, AJ, Babiker, A, Marsh, J W, Outbreak of vancomycin-resistant Enterococcus faecium in interventional radiology: detection through whole genome sequencing-based surveillance (2020) Clin Infect Dis, 70, pp. 2336-2343; Hetem, DJ, Bootsma, MC, Bonten, MJ., Prevention of surgical site infections: decontamination with mupirocin based on preoperative screening for Staphylococcus aureus carriers or universal decontamination? (2016) Clin Infect Dis, 62, pp. 631-636; McNeil, JC, Ligon, JA, Hulten, KG, Staphylococcus aureus Infections in Children With Congenital Heart Disease (2013) J Pediatr Infect Dis Soc, 2, pp. 337-344; Rocha, LA, Ferreira de Almeida, E, Borges, L, Gontijo Filho, P P., Changes in hands microbiota associated with skin damage because of hand hygiene procedures on the health care workers (2009) Am J Infect Control, 37, pp. 155-159; Kownatzki, E., Hand hygiene and skin health (2003) J Hosp Infect, 55, pp. 239-245; Larson, E, Girard, R, Pessoa-Silva, CL, Boyce, J, Donaldson, L, Pittet, D., Skin reactions related to hand hygiene and selection of hand hygiene products (2006) Am J Infect Control, 34, pp. 627-635; Burnham, CA, Hogan, PG, Wallace, MA, Topical decolonization does not eradicate the skin microbiota of community-dwelling or hospitalized adults (2016) Antimicrob Agents Chemother, 60, pp. 7303-7312; Cassir, N, Papazian, L, Fournier, PE, Raoult, D, La Scola, B., Insights into bacterial colonization of intensive care patients' skin: the effect of chlorhexidine daily bathing (2015) Eur J Clin Microbiol Infect Dis, 34, pp. 999-1004; Kates, AE, Zimbric, ML, Mitchell, K, Skarlupka, J, Safdar, N., The impact of chlor-hexidine gluconate on the skin microbiota of children and adults: a pilot study (2019) Am J Infect Control, 47, pp. 1014-1016; SanMiguel, AJ, Meisel, JS, Horwinski, J, Zheng, Q, Bradley, C W, Grice, EA., Antiseptic agents elicit short-term, personalized, and body site-specific shifts in resident skin bacterial communities (2018) J Invest Dermatol, 138, pp. 2234-2243; Woodworth, MH, Hayden, MK, Young, VB, Kwon, JH., The role of fecal micro-biota transplantation in reducing intestinal colonization with antibiotic-resistant organisms: the current landscape and future directions (2019) Open Forum Infect Dis, 6, p. ofz391; Sherry, L, Ramage, G, Kean, R, Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris (2017) Emerg Infect Dis, 23, pp. 328-331; Moore, G, Schelenz, S, Borman, AM, Johnson, EM, Brown, CS., Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris (2017) J Hosp Infect, 97, pp. 371-375; Abdolrasouli, A, Armstrong-James, D, Ryan, L, Schelenz, S., In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris (2017) Mycoses, 60, pp. 758-763; Eyre, DW, Sheppard, AE, Madder, H, A Candida auris outbreak and its control in an intensive care setting (2018) N Engl J Med, 379, pp. 1322-1331; Pacilli, M, Kerins, JL, Clegg, WJ, Regional emergence of Candida auris in Chicago and lessons learned from intensive follow-up at one ventilator-capable skilled nursing facility (2020) Clin Infect Dis, p. ciaa435. , Epub ahead of print; Schelenz, S, Hagen, F, Rhodes, JL, First hospital outbreak of the globally emerging Candida auris in a European hospital (2016) Antimicrob Resist Infect Control, 5, p. 35; Vallabhaneni, S, Kallen, A, Tsay, S, Investigation of the first seven reported Cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-United States, May 2013-August 2016 (2017) Am J Transplant, 17, pp. 296-299